Cargando…
A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery
Members of the solute carrier (SLC) transporter protein family are increasingly recognized as therapeutic drug targets. The majority of drug screening assays for SLCs are based on the uptake of radiolabeled or fluorescent substrates. Thus, these approaches often have limitations that compromise on t...
Autores principales: | Sijben, Hubert J., van den Berg, Julie J. E., Broekhuis, Jeremy D., IJzerman, Adriaan P., Heitman, Laura H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809260/ https://www.ncbi.nlm.nih.gov/pubmed/33446713 http://dx.doi.org/10.1038/s41598-020-79218-w |
Ejemplares similares
-
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters
por: Dvorak, Vojtech, et al.
Publicado: (2021) -
MPP(+)-Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition
por: Mocking, Tamara A. M., et al.
Publicado: (2022) -
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors
por: Sijben, Hubert J., et al.
Publicado: (2021) -
Proteochemometric
Modeling Identifies Chemically Diverse
Norepinephrine Transporter Inhibitors
por: Bongers, Brandon J., et al.
Publicado: (2023) -
Impedance-Based Phenotypic Readout of Transporter Function: A Case for Glutamate Transporters
por: Sijben, Hubert J., et al.
Publicado: (2022)